Of the Field

BIO International 2026

B

IO International 2026 is the industry's largest partnering conference representing the full biotech ecosystem, taking place at the San Diego Convention Center. The event brings together biopharma teams to deliver integrated solutions, accelerate clinical development, reduce risks, and improve commercialization outcomes. Featuring a wide range of insights, n…

Visit the official site
41Voices
59Underwriters
0Exhibitors
0On the bill · sessions
96Companies · in total
§I

The Voices

Programmed at BIO, in alphabetical order.
Alexis Bortniker
Partner · Cooley LLP
Alex Seyferth
Managing Director · Centerview Partners
Alina Meltaus
Chief of Staff · National Security Commission on Emerging Biotechnology (NSCEB)
Andrew Geall
Chief Development Officer · Replicate Bioscience
Chirfi Guindo, MBA
Executive Vice President, Strategic Access, Policy & Communications · Merck
Cynthia Isaac, PhD
Moderator
Daniel Capone
Director, Strategy & Operations · RegCell, Inc.
David Arthur
VP of Strategy · BostonGene
Elizabeth Jungman
Partner · Hogan Lovells
Geoff Biegler
Partner · Cooley
Gyu Hyun (George) NAM
CBO · DigmBio
Hana Samet, MSc
Co-founder & CTO · TheraMe! AG
H.E. Khalid Alburikan
Deputy Minister of Health for Investment · Ministry of Health - Kingdom of Saudi Arabia
Hilary Marston
Principal · Canal Row Advisors
Jake Lesnik
Mekonos
Jesse McCool, PhD
President/COO · GBI Biomanufacturing
Joanna Stanicka, PhD
CEO and Scientific Co-founder · Axonis Therapeutics, Inc.
John C. Reed
Executive Vice President, Innovative Medicine, R&D · Johnson & Johnson
Joshua Kresk
Research Professor and Executive Director of The IP Policy Institute (Ippi) · The University of Akron School of Law
Joshua Meier
Co-Founder · Chai Discovery
Jue Wang, PhD
Global Head of Business Development · Insilico Medicine
Justin Pine
Public Policy Director · Regeneron

— and 19 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
AbbVie Inc.Conference
ACADIA Pharmaceuticals, IncConference
AiluxChampion
AlixPartnersChampion
Alnylam PharmaceuticalsConference
AmgenDouble Helix
Asahi Kasei Therapeutics CorporationConference
AstraZenecaChampion
BioMarinChampion
Boehringer IngelheimHelix
Bora BiologicsChampion
BOSTAL LLCConference
Catalyst PharmaceuticalsChampion
ChubbChampion
City of PhoenixConference
Daiichi SankyoPremier
DNB Carnegie | Back Bay HealthcareConference
Eli Lilly and CompanyDouble Helix
EnzeneConference
Ergomed Clincal ResearchConference
EversanaConference
FujifilmChampion
GenentechDouble Helix
IDT BiologikaConference
InpharmusConference
Invest Puerto RicoPremier
JobsOhioConference
Johnson & JohnsonPremier
KindevaConference
KyboraConference
Kyoto UniversityConference
LabcorpConference
Life Sciences PennsylvaniaConference
MerckDouble Helix
New York StateConference
NovartisPremier
Novo NordiskHelix
NovotechConference
Nxera PharmaPremier
OcugenConference
Intermission
Part the Second · For the Buyer

What does it mean when 96 companies show up — and 2 bet on three roles at once?

“96 companies. two are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
2All threespeak · spons · exh
57Sponsoringsponsor only
0Exhibitingexhibitor only
37Companies Speakingspeaker only

The Triple-Threat

Johnson & Johnson·Merck

№ 02Fig. 02 — The Voices, by Seniority

71% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1127%
  • Founder / Owner512%
  • VP-level410%
  • Director / Head of922%
  • Manager / Lead410%
  • Other roles820%

Of 41 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01Johnson & JohnsonSp·P2V
  2. 02MerckSp·D1V
  3. 03AbbVieSp·C
  4. 04Acadia PharmaceuticalsSp·C
  5. 05AiluxSp·C
  6. 06AlixPartnersSp·C
  7. 07Alnylam PharmaceuticalsSp·C
  8. 08AmgenSp·D
  9. 09Asahi Kasei Therapeutics CorporationSp·C
  10. 10AstraZenecaSp·C
  11. 11BioMarinSp·C
  12. 12Boehringer IngelheimSp·H
  13. 13Bora BiologicsSp·C
  14. 14BOSTAL LLCSp·C
№ 04Fig. 04 — By Tier
champion16
27% of 59
conference26
44% of 59
double helix6
10% of 59
helix2
3% of 59
premier9
15% of 59
№ 05Fig. 05 — The Missing · who's at peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

№ 06Fig. 06 — Adjacent Convocations · by shared underwriters